These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25676454)

  • 1. Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.
    Pana ZD; Kougia V; Roilides E
    Expert Opin Pharmacother; 2015 Apr; 16(5):693-710. PubMed ID: 25676454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M
    J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients.
    Filioti I; Iosifidis E; Roilides E
    Expert Opin Pharmacother; 2008 Dec; 9(18):3179-96. PubMed ID: 19040339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of invasive fungal infections: a role for polyenes.
    Chandrasekar P
    J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic antifungal agents used after lung transplantation.
    Marino E; Gallagher JC
    Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer antifungal agents.
    Larru B; Zaoutis TE
    Curr Opin Pediatr; 2013 Feb; 25(1):110-5. PubMed ID: 23263025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy approaches to antifungal prophylaxis.
    Ng TB; Cheung RC; Ye Xj; Fang EF; Chan YS; Pan WL; Dan XL; Yin CM; Lam SK; Lin P; Ngai PH; Xia LX; Liu F; Ye XY; Wang HX; Wong JH
    Expert Opin Pharmacother; 2012 Aug; 13(12):1695-705. PubMed ID: 22716311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
    Almyroudis NG; Segal BH
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1451-66. PubMed ID: 21133669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
    Maximova N; Schillani G; Simeone R; Maestro A; Zanon D
    Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal treatment in pediatric patients.
    Zaoutis TE; Benjamin DK; Steinbach WJ
    Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current role of amphotericin B lipid complex in managing systemic fungal infections.
    Chu P; Sadullah S
    Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New agents for invasive mycoses in children.
    Antachopoulos C; Walsh TJ
    Curr Opin Pediatr; 2005 Feb; 17(1):78-87. PubMed ID: 15659969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antifungal agents in pediatric practice.
    Das S; Shivaprakash MR; Chakrabarti A
    Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary antifungal prophylaxis in pediatric hematopoietic stem cell transplants.
    Azik FM; Tezer H; Ozkaya-Parlakay A; Aksu T; Bayram C; Fettah A; Tavil B; Tunç B
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e19-22. PubMed ID: 25522351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fungal infections in children with malignant disease].
    Michel G
    Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.